SPARC and neoplasm: SPARC overexpression has been repeatedly confirmed in diverse cancers with different histologies including hepatocellular carcinoma (HCC) [7] and esophageal squamous cell carcinoma (ESCC) [8], suggesting that SPARC overexpression in primary tumor tissues may be a common feature representing TME activation across human cancers.